Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
443
-
Shares change
-
+378
-
Total reported value, excl. options
-
$2.96K
-
Value change
-
+$2.53K
-
Number of buys
-
1
-
Price
-
$6.69
Significant Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q3 2024
2 filings reported holding SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW as of Q3 2024.
Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 443 shares
.
Largest 2 shareholders include Tower Research Capital LLC (TRC) (378 shares) and BlackRock, Inc. (65 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.